Extract of Ginkgo Biloba (EGB 761) and Vascular Function

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

July 31, 2005

Conditions
Intermittent ClaudicationPeripheral Vascular Disease
Interventions
DRUG

Gingko Biloba (Herb)

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00029991 - Extract of Ginkgo Biloba (EGB 761) and Vascular Function | Biotech Hunter | Biotech Hunter